Cell Press is pleased to announce the second iteration of this symposium, thus providing a platform in which to share key advances and promote scientific collaboration. We will assemble leading experts to discuss basic immunology, cancer-immune cell interactions, and how tumor-associated inflammation can be reprogrammed for therapeutic benefit and to examine new approaches to cancer immunotherapy. Thus, we invite academic and industry scientists as well as clinicians to explore the key outstanding questions of tomorrow.
- Inflammation and tumorigenesis
- The immune system and the tumor microenvironment
- Tumor immunosurveillance and defense
- Modulating inflammatory responses to cancer
- Cancer Immunotherapy